Cerba Trova
About Us
About Us
Corporate Social Responsibility
Careers
Location
Our People
Virtual Laboratory Tours
Specialty Laboratory Solutions
Anatomic Pathology & Tissue Analysis
Digital Imaging & Analysis
Early and Pre-Clinical Tissue Solutions
IHC Antibody Development Solutions
Imaging Mass Cytometry (IMC)
Immunohistochemistry (IHC) Services
Multiplex IHC & (IF)
RNAscope® In Situ Hybridization Assay
Spatial Omics
Assay Development & Technology Transfer
Bioanalytical Solutions
Biomarkers
Cell & Gene Therapy Laboratory Solutions
Data Intelligence
Flow Cytometry
Flow Cytometry Panels And Biomarkers
Flow Cytometry Custom Assay Development
Scientific Project Management
Reporting
Genomics
Constitutional Genomics
DNA/RNA Extraction
Genomics for Infectious Diseases
Immune Repertoire Sequencing
Next Generation Sequencing Capabilities
Next-Generation Sequencing For Solid Tumors
Next-Generation Sequencing For Hematological Malignancies
Next-Generation Sequencing For Liquid Biopsies
Immunoassay
Pre-clinical Services
Pre-Analytical And PBMC Processing
Virology & Vaccine Laboratory
Central Laboratory Solutions
Biotech Lab Solution
Central & Specialty Clinical Trial Laboratory Solutions
Data Quality & Accreditation
Global Laboratory Network
Logistics
Specialty Diagnostic Kits
Project Management
Protocol Development
Safety Testing
Trial Phases
Therapeutic Areas
Inflammation & Immunology
Infectious Diseases And Vaccines
Virology, Bacteriology & Vaccines Development
Metabolics
Neuroscience
Oncology
Hematological Malignancies
Multiple Myeloma
Solid Tumors
Breast Cancer
Colorectal Cancer
Immuno-oncology
Lung Cancer
Rare Diseases
Insights
Events & Conferences
Resource Library
Scientific & Therapeutic Publications
Search
Contact Us
Contact Us
About Us
Corporate Social Responsibility
Careers
Location
Our People
Virtual Laboratory Tours
Specialty Laboratory Solutions
Anatomic Pathology & Tissue Analysis
Digital Imaging & Analysis
Early and Pre-Clinical Tissue Solutions
IHC Antibody Development Solutions
Imaging Mass Cytometry (IMC)
Immunohistochemistry (IHC) Services
Multiplex IHC & (IF)
RNAscope® In Situ Hybridization Assay
Spatial Omics
Assay Development & Technology Transfer
Bioanalytical Solutions
Biomarkers
Cell & Gene Therapy Laboratory Solutions
Data Intelligence
Flow Cytometry
Flow Cytometry Panels And Biomarkers
Flow Cytometry Custom Assay Development
Scientific Project Management
Reporting
Genomics
Constitutional Genomics
DNA/RNA Extraction
Genomics for Infectious Diseases
Immune Repertoire Sequencing
Next Generation Sequencing Capabilities
Next-Generation Sequencing For Solid Tumors
Next-Generation Sequencing For Hematological Malignancies
Next-Generation Sequencing For Liquid Biopsies
Immunoassay
Pre-clinical Services
Pre-Analytical And PBMC Processing
Virology & Vaccine Laboratory
Central Laboratory Solutions
Biotech Lab Solution
Central & Specialty Clinical Trial Laboratory Solutions
Data Quality & Accreditation
Global Laboratory Network
Logistics
Specialty Diagnostic Kits
Project Management
Protocol Development
Safety Testing
Trial Phases
Therapeutic Areas
Inflammation & Immunology
Infectious Diseases And Vaccines
Virology, Bacteriology & Vaccines Development
Metabolics
Neuroscience
Oncology
Hematological Malignancies
Multiple Myeloma
Solid Tumors
Breast Cancer
Colorectal Cancer
Immuno-oncology
Lung Cancer
Rare Diseases
Insights
Events & Conferences
Resource Library
Scientific & Therapeutic Publications
Home
»
Article – The Value Of Biomarkers From Discovery To Commercialization
Article – The Value Of Biomarkers From Discovery To Commercialization
Created: January 15, 2025
